Portal de Periódicos da CAPES

Artigo Produção Nacional Revisado por pares

BIBTEX RIS

Decompensated cirrhosis and liver transplantation negatively impact in DAA treatment response: Real‐world experience from HCV‐LALREAN cohort

2020; Wiley; Volume: 92; Issue: 12 Linguagem: Inglês

10.1002/jmv.26383

1096-9071

Ezequiel Ridruejo, Federico Piñero, Manuel Mendizábal, Hugo Cheinquer, Fernando Herz Wolff, Margarita Anders, Virginia Reggiardo, Beatriz Ameigeiras, Ana Palazzo, Cristina Alonso, María Isabel Schinoni, María Grazia Videla Zuain, Federico Tanno, Sebastián Figueroa, Luisa Santos, Mirta Peralta, Alejandro Soza, Cecilia Vistarini, Raúl Adrover, Nora Fernández, Daniela Perez, Nelia Hernández, Claudio Estepo, Andrés Bruno, Valeria Descalzi, Marcela Sixto, Silvia Borzi, Daniel Cocozzella, Alina Zerega, Alexandre de Araújo, Adriana Varón, Marcelo Silva,

Liver Disease and Transplantation

Although the effectiveness of direct-acting antivirals (DAAs) for the treatment of chronic hepatitis C virus (HCV) has been reported in real-world settings, predictive factors of treatment failure are lacking. Therefore, we sought to explore the baseline predictors of treatment response to DAAs.